Preventing the production of toxic mitochondrial proteins—a promising treatment target

phys.org | 2/22/2019 | Staff
normanorma (Posted by) Level 4
Click For Photo: https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/hires/2014/1-mitochondria.png




Researchers at the University of Helsinki uncovered the mechanisms for a novel cellular stress response arising from the toxicity of newly synthesized proteins. Activation of the stress response is at the epicentre of the molecular events generated by genetic mutations that cause a complex neurological syndrome.

In all living organisms, the ability to translate the genetic code into proteins is the definitive step in gene expression. Mitochondria are known as the powerhouse of the cell and an indispensable organelle with a unique genome and a dedicated protein synthesis machinery. [KEE1] In humans, mitochondrial DNA is only inherited from the mother and encodes only 13 proteins essential for energy metabolism. Defects in the faithful synthesis of these 13 proteins represents the largest group of inherited human mitochondrial disorders, which display exceptional clinical heterogeneity in terms of presentation and severity. Disruptions to energy metabolism alone do not explain the disease mechanism.

Ability - Treat - Patients - Understanding - Pathogenesis

"The ability to treat patients has been stymied because of the fragmented understanding of the molecular pathogenesis and thus, bridging this knowledge gap is critical," says Research Director Brendan Battersby from the Insitute of Biotechnology, University of Helsinki.

AFG3L2 genes act as mitochondrial quality control regulator, preventing the accumulation of toxic translation products and thereby keeps the organelle and cell healthy. Mutations in the genes AFG3L2 and paraplegin cause a...
(Excerpt) Read more at: phys.org
Wake Up To Breaking News!
Homeschool or State Thought Police School, you choose.
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!